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ABSTRACT 
In this study, we investigated the ability of 6,7-dimethoxy-4-methylcoumarin (DMC) to inhib-
it lipopolysaccharide (LPS)-induced expression of pro-inflammatory mediators in mouse 
macrophage (RAW 264.7) cells, and the molecular mechanism through which this inhibition 
occurred. Our results indicated that DMC downregulated LPS-induced nitric oxide (NO) syn-
thase (iNOS) and cyclooxygenase-2 (COX-2) expression, thereby reducing the production of 
NO and prostaglandin E2 (PGE2) in LPS-activated RAW 264.7 cells. Furthermore, DMC sup-
pressed LPS-induced production of pro-inflammatory cytokines such as interleukin (IL)-1β, 
IL-6, and tumor necrosis factor (TNF)-α. To elucidate the mechanism underlying the anti-
inflammatory activity of DMC, we assessed its effects on the mitogen-activated protein ki-
nase (MAPK) pathway and the activity and expression of nuclear transcription factor kappa-B 
(NF-κB). The experiments demonstrated that DMC inhibited LPS-induced phosphorylation of 
extracellular signal-regulated kinases (ERKs), c-Jun N-terminal kinase (JNK), and p38. In 
addition, it attenuated LPS-induced NF-κB activation via the inhibition of IκB-α phosphoryla-
tion. Taken together, these data suggest that DMC exerts its anti-inflammatory effects in 
RAW 264.7 cells through the inhibition of LPS-stimulated NF-κB and MAPK signaling, 
thereby downregulating the expression of pro-inflammatory mediators.  
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INTRODUCTION 
Inflammation is an essential host defense 
mechanism that can be induced in response 
to a wide variety of exogenous and endoge-
nous stimuli (Lawrence et al., 2002). Lipo-
polysaccharide (LPS) is a potent immune 
system activator, inducing local inflamma-
tion, antibody production, septic shock, fe-
ver, and death (Rietschel and Brade, 1992). 
LPS activation of macrophages results in the 
upregulation of cyclooxygenase-2 (COX-2) 
and inducible nitric oxide (NO) synthase 
(iNOS) expression and the release of NO, 
prostaglandin E2 (PGE2), and inflammatory 
cytokines such as interleukin (IL)-1β, IL-6, 
and tumor necrosis factor (TNF)-α, which 
can in turn activate other macrophages and 
nearby cells (Fujiwara and Kobayashi, 2005; 
Lawrence et al., 2002). Overproduction of 
inflammatory mediators is involved in the 
pathophysiology of chronic inflammatory 
diseases, such as rheumatoid arthritis, diabe-
tes, and cancer (Feldmann, 2008; Serhan and 
Savill, 2005). Therefore, understanding the 
pathways that regulate the release of in-
flammatory mediators from activated macro-
phages is important for the development of 
novel therapeutics for the treatment of in-
flammatory diseases. 
Previous studies have shown that com-
pared to untreated macrophages, LPS-
activated macrophages have a higher level of 
active nuclear transcription factor kappa-B 
(NF-κB), which regulates the production of 
pro-inflammatory cytokines and inflammato-
ry mediators (Kim et al., 2013a; Ruland, 
2011). Further, the mitogen-activated protein 
kinase (MAPK) pathway is also activated in 
LPS-stimulated macrophages and contributes 
to the inflammatory response (Cargnello and 
Roux, 2011). 
Coumarins are a group of heterocyclic 
compounds synthesized by numerous green 
plant species as well as by some bacteria and 
fungi, and have been widely used as fra-
grances in food and cosmetic products 
(Hoult and Paya, 1996; Lake, 1999). Numer-
ous biological activities have been attributed 
to simple coumarins and coumarin deriva-
tives, including anti-coagulant (Manolov et 
al., 1993), anti-inflammatory (Fylaktakidou 
et al., 2004; Kontogiorgis and Hadjipavlou-
Litina, 2003), anti-viral (Kostova et al., 
2006), antimicrobial (Nagamallu and Kari-
yappa, 2013), and anti-oxidant effects (Naga-
mallu and Kariyappa, 2013; Raj et al., 1998). 
However, the anti-inflammatory effects of 
6,7-dimethoxy-4-methylcoumarin (DMC) in 
RAW 264.7 macrophages and the molecular 
mechanisms regulating these effects remain 
largely unknown. The present study aimed to 
assess the effects of DMC on LPS-induced 
inflammatory responses in RAW 264.7 mac-
rophages, and to explore the possible molec-
ular mechanisms underlying these activities. 
 
MATERIALS AND METHODS 
Chemicals 
DMC (Figure 1A), 3-(4,5-dimethylthia-
zol-2-yl)-2,5-diphenyltetrazolium bromide 
(MTT), and phosphate-buffered saline (PBS) 
were purchased from Sigma-Aldrich (St. 
Louis, MO, USA). Dulbecco’s modified Ea-
gle’s medium (DMEM) and fetal bovine se-
rum (FBS) were obtained from Invitrogen-
Gibco (Grand Island, NY, USA). Enzyme-
linked immunosorbent assay (ELISA) kits 
for PGE2, TNF-α, IL-1β, and IL-6 were pur-
chased from R&D Systems, Inc. (St. Louis, 
MO, USA). Anti-iNOS (mouse), Anti-COX-
2 (rabbit), Anti-IκB-α (mouse), anti-phos-
phorylated IκB-α (rabbit, anti-p-IκB-α), anti-
c-Jun N-terminal kinase (rabbit, JNK), anti-
phosphorylated JNK (rabbit, anti-p-JNK), 
anti-extracellular signal-regulated kinases 
(rabbit, ERK1/2), anti-phosphorylated 
ERK1/2 (rabbit, anti-p-ERK1/2), anti-p38 
(rabbit), and anti-phosphorylated p38 (rabbit, 
anti-p-p38) mouse or rabbit antibodies were 
purchased from Cell Signaling Technology 
(Beverly, MA, USA). All other reagents 
were purchased from the Sigma-Aldrich 
Chemical Co. (St. Louis, MO, USA). 
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Figure 1: Effect of DMC on RAW 264.7 cell via-
bility. (A) Chemical structure of DMC. (B) RAW 
264.7 cells (1.5 × 105 cells/ml) plated on 96-well 
plates were treated with DMC at 37 °C for 24 h. 
Cytotoxicity of DMC was assessed by MTT as-
say. Values are expressed as means ± S.D. of 
triplicate experiments. *P < 0.05 for the compari-
son with the LPS-stimulated group 
 
 
Cell culture 
The murine RAW 264.7 macrophage cell 
line was obtained from the Korean Cell Line 
Bank (KCLB; Seoul, Korea) and cultured in 
DMEM supplemented with 100 U/ml peni-
cillin, 100 μg/ml streptomycin, and 10 % 
FBS. The cells were then incubated in an 
atmosphere of 5 % CO2 at 37 °C and were 
sub-cultured every 3 days. 
 
Cell viability assay 
The effect of DMC on RAW 264.7 cell 
viability was assessed using a colorimetric 
MTT assay. The cells (1.5 × 105 cells/well) 
were pre-incubated for 18 h and then incu-
bated with or without LPS (1 μg/ml) in the 
absence or presence of various concentra-
tions (100, 200, and 400 μM) of DMC for 
24 h. MTT stock solution (50 μl; 2 mg/ml in 
PBS) was added to each well to achieve a 
total reaction volume of 250 μl. After incu-
bation for 4 h, the plates were centrifuged for 
10 min at 2000 rpm, and the supernatants 
were aspirated. The formazan crystals in 
each well were dissolved in dimethylsulfox-
ide. The amount of purple formazan was as-
sessed by measuring the absorbance at 
540 nm.  
 
NO determination 
Cells (1.5 × 105 cells/well) were pre-
incubated for 18 h and then incubated with 
or without LPS (1 μg/ml) in the absence or 
presence of various concentrations (100, 
200, and 400 μM) of DMC for 24 h. The ni-
trite in the medium was measured by per-
forming Griess assay and used as an indica-
tor of cellular NO synthesis. Culture super-
natants were mixed with Griess reagent (1:1 
mixture of 1 % sulfanilamide and 0.1 % 
naphthylethylenediamine dihydrochloride in 
2.5 % phosphoric acid) and incubated at 
room temperature for 10 min. The absorb-
ance at 540 nm was then measured in a mi-
croplate reader. Samples of fresh culture me-
dia were used as blanks for all experiments. 
The nitrite levels in the samples were deter-
mined using a standard sodium nitrite curve. 
 
ELISA 
The levels of PGE2, TNF-α, IL-1β, and 
IL-6 in the culture media were quantified 
using ELISA kits. Briefly, cells (1.5 × 105 
cells/well) were pre-incubated for 18 h and 
then incubated with or without LPS (1 μg/ 
ml) in the absence or presence of various 
concentrations (100, 200, and 400 μM) of 
DMC for 24 h. Cell-free supernatants were 
collected for ELISA determination of PGE2, 
IL-1β, IL-6, and TNF-α concentrations in 
accordance with the manufacturer’s instruc-
tions. 
 
Western blot analysis 
Cells (1.5 × 105 cells/well) were pre-
incubated for 18 h and then incubated with 
or without LPS (1 μg/ml) in the absence or 
presence of various concentrations (100, 
200, and 400 μM) of DMC for 24 h or with 
400 μM DMC for 10, 20, and 30 min. After 
incubation, the cells were collected and 
washed twice with cold PBS. The cells were 
lysed in a lysis buffer (50 mM Tris-HCl [pH 
7.5], 150 mM NaCl, 1 % Nonidet P-40, 
2 mM EDTA, 1 mM EGTA, 1 mM NaVO3, 
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10 mM NaF, 1 mM dithiothreitol, 1 mM 
phenylmethylsulfonyl fluoride, 25 μg/ml 
aprotinin, and 25 μg/ml leupeptin) and main-
tained on ice for 30 min. The cell lysates 
were centrifuged, and the protein concentra-
tions were determined using a BCA™ pro-
tein assay kit. Aliquots of the lysates (40 μg 
of protein) were separated on a 12 % sodium 
dodecyl sulfate-polyacrylamide gel and 
transferred onto a polyvinylidene fluoride 
(PVDF) membrane (BIO-RAD) using a gly-
cine transfer buffer (192 mM glycine, 
25 mM Tris-HCl [pH 8.8], 20 % methanol 
[v/v]). After blocking nonspecific binding 
sites with 1 % bovine serum albumin (BSA), 
the membrane was incubated overnight with 
a specific primary antibody (1:1000) at 4 °C. 
The membrane was then incubated for an 
additional 60 min with a peroxidase-conjug-
ated secondary antibody (1:5000, Vector La-
boratories, Burlingame, CA, USA) at room 
temperature. The immunoactive protein 
bands were detected using an enhanced 
chemiluminescence (ECL) western blotting 
detection kit. 
 
Statistical analysis 
All data are expressed as means ± stand-
ard deviation (S.D.). Significant differences 
among the groups were determined using the 
unpaired Student’s t-test. A value of *p < 
0.05 was considered to be statistically signif-
icant. 
 
RESULTS 
Effect of DMC on RAW 264.7 cell viability 
To assess whether DMC affected the vi-
ability of RAW 264.7 cells, MTT assays 
were performed 24 h after treatment with the 
indicated concentrations of DMC, in the 
presence or absence of LPS. The results in-
dicated that cell viability was not affected by 
DMC at concentrations of up to 400 μM 
(Figure 1B). Thus, DMC did not show any 
cellular toxicity in RAW 264.7 cells. 
 
DMC inhibited iNOS and COX-2 expres-
sion and the subsequent production of NO 
and PGE2 in LPS-induced RAW 264.7 cells 
To investigate the potential anti-inflam-
matory effects of DMC, RAW 264.7 cells 
were stimulated with LPS for 24 h in the 
presence or absence of DMC (100, 200, and 
400 μM) and NO and PGE2 production was 
analyzed. Compared to the control group, 
treatment of RAW 264.7 cells with LPS 
alone resulted in a significant increase in NO 
and PGE2 production. However, DMC inhib-
ited LPS-induced production of NO and 
PGE2 in a dose-dependent manner (Figure 
2A and B). In order to determine if the inhib-
itory effects of DMC on NO and PGE2 pro-
duction were due to changes in iNOS and 
COX-2 levels, we examined their expression 
levels by western blot. This analysis identi-
fied a marked increase in the expression of 
iNOS and COX-2 24 h after LPS treatment. 
However, DMC strongly inhibited iNOS and 
COX-2 protein expression in a concentra-
tion-dependent manner (Figure 2C). These 
results suggested that DMC inhibited NO 
and PGE2 release by reducing iNOS and 
COX-2 expression. 
 
DMC inhibited LPS-induced production of 
pro-inflammatory cytokines in RAW 264.7 
cells 
We next determined the effect of DMC 
on IL-1β, IL-6, and TNF-α production in 
LPS-induced RAW 264.7 cells. IL-1β, IL-6, 
and TNF-α levels significantly increased in 
the culture media of LPS-stimulated RAW 
264.7 cells, and the levels of these cytokines 
showed significant, concentration-dependent, 
decreases in the presence of DMC (Figure 
3). 
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Figure 2: Effect of DMC on LPS-induced ex-
pression of iNOS and COX-2 and production of 
NO and PGE2 in RAW 264.7 cells. Cells were 
stimulated with LPS (1 μg/ml) in the presence of 
DMC (100, 200, and 400 μM) for 24 h at 37 °C. 
(A) Culture media were collected in order to 
measure (A) NO and (B) PGE2 production by the 
Griess reaction and ELISA, respectively. Values 
are expressed as means ± S.D. of triplicate ex-
periments. *P < 0.05 for the comparison with the 
LPS-stimulated group. (C) Cells were stimulated 
with LPS (1 μg/ml) in the presence of DMC (100, 
200, and 400 μM) for 24 h at 37 °C. The levels of 
iNOS and COX-2 proteins in cell lysates were 
analyzed by western blot. 
 
 
DMC inhibited LPS-induced NF-κB activa-
tion in RAW 264.7 cells 
NF-κB has been shown to regulate the 
expression of iNOS and COX-2 following 
stimulation by LPS or other inflammatory 
cytokines (Gloire et al., 2006). Therefore, we 
investigated whether DMC inhibited the NF-
κB signaling pathway in LPS-stimulated 
RAW 264.7 cells. Western blot analysis re-
vealed that 400 μM DMC treatment inhibited 
LPS-induced NF-κB (p65 and p50) activa-
tion (Figure 4). We also found that treatment 
of LPS-stimulated cells with 400 μM DMC 
significantly decreased IκB-α phosphoryla-
tion and degradation, compared to that ob-
served in the cells treated with LPS alone 
(Figure 4). 
 
 
Figure 3: Inhibitory effect of DMC on pro-
inflammatory cytokine production in RAW 264.7 
cells. The production of (A) TNF-α, (B) IL-6, and 
(C) IL-1β were assayed in the culture medium of 
cells stimulated with LPS (1 μg/ml) for 24 h in the 
presence of DMC (100, 200, and 400 μM). The 
concentrations of TNF-α, IL-6, and IL-1β in the 
supernatants were determined by ELISA. Values 
are expressed as means ± S.D. of triplicate ex-
periments. *P < 0.05. 
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Figure 4: Inhibitory effects of DMC on LPS-
induced phosphorylation of IκB-α and NF-κB 
p50. Cells were treated for different times (10, 
20, and 30 min) with LPS (1 μg/ml), alone or with 
400 μM DMC, as indicated. The levels of p-IκB-α 
(phosphorylated-IκB-α), IκB-α, p-p50 (phos-
phorylated p50) and p-p65 (phosphorylated p65) 
were determined by western blotting. 
 
 
DMC inhibited LPS-induced MAPK phos-
phorylation in RAW 264.7 cells 
To determine whether DMC inhibited the 
production of pro-inflammatory mediators 
through effects on the MAPK pathway, we 
evaluated the effect of DMC on LPS-induced 
phosphorylation of p38, JNK, and ERK in 
RAW 264.7 cells using western blotting. We 
found that LPS stimulation significantly in-
creased phosphorylation of p38, JNK, and 
ERK. However, treatment with 400 μM 
DMC attenuated the phosphorylation of 
these proteins (Figure 5). 
 
DISCUSSION 
Macrophages play a key role in immune 
responses during the inflammation process. 
After macrophages are activated by LPS, 
large amounts of inflammatory mediators are 
released (Lee et al., 2012). Because of this, 
LPS-induced macrophages have been used to 
assess the anti-inflammatory effects of vari-
ous agents. The present study sought to elu-
cidate the pharmacological effects of DMC 
on the production of pro-inflammatory me-
diators, and its mechanism of action, in LPS-
stimulated RAW 264.7 macrophages. We 
found that DMC significantly inhibited LPS-
induced NO, PGE2, TNF-α, IL-1β, and IL-6 
production in RAW 264.7 cells through the 
suppression of NF-κB and MAPK activation. 
 
 
Figure 5: Inhibitory effects of DMC on ERK, 
JNK, and p38 protein levels in RAW 264.7 cells. 
Cells were treated for different times (10, 20, and 
30 min) with LPS (1 μg/ml), alone or with 400 μM 
DMC, as indicated. The levels of p-ERK (phos-
phorylated-ERK), ERK, p-JNK (phosphorylated-
JNK), JNK, p-p38 (phosphorylated-p-38) and p-
38 were determined by western blotting. 
 
 
Macrophages stimulated by LPS or other 
cytokines overexpress iNOS, which metabo-
lizes L-arginine to L-citrulline and NO (Jiang 
et al., 2012). NO assists in the activation of 
macrophages by regulating signal transduc-
tion to enhance the ability of macrophages to 
kill microorganisms (Olefsky and Glass, 
2010). However, overproduction of NO by 
macrophages could induce innate immunity 
and cause an inflammatory response (Yan 
and Hansson, 2007). In acute and chronic 
inflammatory diseases, including asthma, 
arthritis, atopic dermatitis, and fever caused 
by bacterial infection, macrophages are acti-
vated and release more NO, causing tissue 
injury (Caplin and Leiper, 2012; Yan and 
Hansson, 2007; Zhou et al., 2012). There-
fore, regulation of NO release through the 
inhibition of iNOS may alleviate inflamma-
tion. Because our results indicated that DMC 
decreased NO and PGE2 production via the 
suppression of iNOS and COX-2 expression 
in LPS-stimulated RAW 264.7 cells, it may 
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be useful for the treatment of NO- and PGE2-
induced inflammatory responses.  
Similar to NO, PGE2 is a pleiotropic sig-
naling molecule produced in considerable 
quantities by COX-2 at sites of inflamma-
tion. It has also been reported to be involved 
in the pathogenesis of inflammatory diseases 
(Lipsky, 1999; Zhang et al., 2011). Thus, 
chemopreventive agents that attenuate COX-
2-mediated PGE2 production have had a 
therapeutic effect in many inflammatory dis-
eases (Hocherl et al., 2002). In the present 
study, we found that DMC inhibited PGE2 
production in LPS-stimulated RAW 264.7 
cells by reducing the expression of COX-2. 
These data suggested that the inhibition of 
NO and PGE2 production by DMC may be 
due to its suppression of iNOS and COX-2 
upregulation during activation of macro-
phages by LPS. Importantly, the inhibitory 
effect of DMC on LPS-induced iNOS and 
COX-2 expression did not result from its cy-
totoxicity, because there was no observable 
loss of cell viability in our MTT assays. 
Inflammatory stimuli such as LPS induce 
the production of cytokines, including TNF-
α, IL-6, and IL-1β, during macrophage acti-
vation. These cytokines can then mediate 
tissue responses during different phases of 
inflammation (Hseu et al., 2005; Kim et al., 
2013b). TNF-α has many physiological ef-
fects, including promotion of inflammation 
and apoptosis, and the overproduction of 
TNF-α may cause tissue injury, sepsis, or 
death (Chong and Sriskandan, 2011). IL-6 is 
an important cytokine released in many im-
munological and inflammatory responses 
(Liu et al., 2011). In addition, IL-1β is an 
inflammatory cytokine involved in the in-
duction of innate immune responses by mac-
rophages and in the secretion of other in-
flammatory cytokines (Dinarello, 2011). Be-
cause of their important roles in inflammato-
ry responses, downregulation of these pro-
inflammatory cytokines is of utmost im-
portance during anti-inflammatory therapy. 
Here, we showed that DMC inhibited the 
LPS-induced production of TNF-α, IL-1β, 
and IL-6. 
NF-κB is a key transcription factor regu-
lating the expression of inflammation-
associated enzymes and cytokines, including 
iNOS, COX-2, TNF-α, and IL-1β (Gloire et 
al., 2006). Inactive NF-κB is located in the 
cytoplasm, where it complexes with IκB-α. 
Phosphorylation and degradation of IκB-α 
releases NF-κB, allowing it to translocate to 
the nucleus and initiate the transcription of 
its target genes (Gomez et al., 2005). There-
fore, NF-κB activation could be assessed in 
RAW 264.7 cells by measuring the expres-
sion level of the IκB-α protein. In the present 
study, we found that DMC inhibited LPS-
induced IκB-α phosphorylation and degrada-
tion, and the activation of NF-κB p65 and 
p50. These data suggested that the effects of 
DMC on the production of inflammatory 
mediators and cytokines are mediated, at 
least in part, via suppression of the NF-κB 
signaling pathway. 
MAPK signaling pathways play im-
portant roles in many biological processes, 
including inflammation, apoptosis, prolifera-
tion, and differentiation. The MAPKs in-
clude ERK, JNK, and p38 kinase (Kim et al., 
2010). MAPKs have been reported to pro-
mote iNOS and COX-2 expression in LPS-
stimulated macrophages (Kyriakis and 
Avruch, 2012). In addition, the phosphoryla-
tion of MAPKs promotes the production of 
pro-inflammatory cytokines in LPS-induced 
macrophages (Ajizian et al., 1999; Carter et 
al., 1999). Our results indicated that DMC 
was a potent inhibitor of MAPK activation 
following LPS stimulation of RAW 264.7 
cells, suggesting that its anti-inflammatory 
effects were also due to inhibition of MAPK 
signaling pathways. 
In summary, the present study demon-
strated that DMC was a potent inhibitor of 
NO, PGE2, iNOS, COX-2, IL-6, IL-1β, and 
TNF-α production in LPS-induced RAW 
264.7 cells. These inhibitory actions of DMC 
were mediated through the inhibition of IκB-
α degradation, which prevented the activa-
tion and translocation of NF-κB. Further-
more, the levels of phosphorylated MAPKs 
in LPS-induced RAW 264.7 cells were sig-
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nificantly decreased by treatment with DMC. 
Taken together, the findings led us to con-
clude that DMC appeared to have the poten-
tial to prevent LPS-induced inflammation.  
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